The FDA has flagged this as a potentially high-risk issue, as improper fluid delivery can lead to serious complications such as edema, shortness of breath, high blood pressure and in severe cases, ...
Medline has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of its common ...